Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMEM63C is a mechanosensitive, osmosensitive calcium-permeable cation channel that is preferentially activated by hypotonic stress[1][6]. It belongs to the OSCA/TMEM63 family, structurally characterized by 11 transmembrane helices[1]. TMEM63C primarily exists as a monomer in animal cells and is enriched at mitochondria-endoplasmic reticulum contact sites, where it regulates metabolite flux and organelle morphology in response to osmotic changes[3][6]. TMEM63C plays a role in various physiological processes, including calcium influx, neuronal mitochondrial function, and maintaining the functional integrity of the kidney filtration barrier. Pathogenic mutations are associated with hereditary spastic paraplegia type 87 and may have implications in kidney glomerular diseases like focal segmental glomerulosclerosis[3]. No interacting drugs or mechanisms of action for pharmacological targeting have been reported as of the latest research. Its main biological role is in cellular adaptation to changes in osmotic pressure, making it important for cell-volume regulation and mechanosensation[1][6][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Osmosensitive cation channel TMEM63C (TMEM63C).